CEPHALO-PELVIC DISPROPORTION side effect
What is CEPHALO-PELVIC DISPROPORTION ?CEPHALO-PELVIC DISPROPORTION : Zyprexa Side Effects Report #5620024-6
Physician from JAPAN reported ZYPREXA problem on Jan 29, 2008. Female patient was diagnosed with personality disorder and was treated with ZYPREXA. After drug was administered, patient experienced the following problems/side effects: cephalo-pelvic disproportion, cleft palate, . ZYPREXA dosage: 2.5 MG, DAILY (1/D). Patient recovered.
CEPHALO-PELVIC DISPROPORTION : Zyprexa Side Effects Report #5638625-8
ZYPREXA problem was reported by a Physician from JAPAN on Feb 14, 2008. Male patient, weighting 6.72 lb, was diagnosed with personality disorder, insomnia and was treated with ZYPREXA. After drug was administered, patient experienced the following problems/side effects: cephalo-pelvic disproportion, cleft palate, . ZYPREXA dosage: 2.5 MG, DAILY (1/D). During the same period patient was treated with HALCION, MYSLEE. Patient recovered.
CEPHALO-PELVIC DISPROPORTION : Arimidex Side Effects Report #5473013-9
Consumer or non-health professional from UNITED STATES reported ARIMIDEX problem on Feb 26, 2007. Female patient, 76 years of age, weighting 140.0 lb, was diagnosed with breast cancer female and was treated with ARIMIDEX. After drug was administered, patient experienced the following problems/side effects: cephalo-pelvic disproportion, gastrointestinal disorder, insomnia, intestinal haemorrhage, muscle spasms, . ARIMIDEX dosage: unknown. During the same period patient was treated with RADIATION, ATENOLOL, FOLIC ACID. Patient recovered.
CEPHALO-PELVIC DISPROPORTION : Shakuyaku Side Effects Report #5482935-4
SHAKUYAKU problem was reported by a Health Professional from JAPAN on Aug 30, 2007. Female patient, 28 years of age, weighting 113.1 lb, was diagnosed with pain and was treated with SHAKUYAKU. After drug was administered, patient experienced the following problems/side effects: caesarean section, cephalo-pelvic disproportion, decreased appetite, . SHAKUYAKU dosage: unknown. During the same period patient was treated with PENTAGIN. Patient was hospitalized. Patient recovered.
CEPHALO-PELVIC DISPROPORTION : Gleevec Side Effects Report #5404792-4
Health Professional from UNITED STATES reported GLEEVEC problem on July 27, 2007. Female patient, 32 years of age, weighting 220.5 lb, was diagnosed with chronic myeloid leukaemia and was treated with GLEEVEC. After drug was administered, patient experienced the following problems/side effects: caesarean section, cephalo-pelvic disproportion, normal newborn, . GLEEVEC dosage: 300 MG, QD. During the same period patient was treated with PRENATAL VITAMINS. Patient recovered.
CEPHALO-PELVIC DISPROPORTION : Sandostatin Side Effects Report #5414842-7
SANDOSTATIN LAR problem was reported by a Consumer or non-health professional from JAPAN on Aug 06, 2007. Female patient, 37 years of age, weighting 183.0 lb, was diagnosed with acromegaly and was treated with SANDOSTATIN LAR. After drug was administered, patient experienced the following problems/side effects: caesarean section, cephalo-pelvic disproportion, foetal distress syndrome, induced labour, normal newborn, pregnancy induced hypertension, . SANDOSTATIN LAR dosage: 30 MG, ONCE/SINGLE. During the same period patient was treated with SANDOSTATIN LAR, SANDOSTATIN LAR, SANDOSTATIN LAR, SANDOSTATIN LAR, SANDOSTATIN LAR. Patient was hospitalized. Patient recovered.
CEPHALO-PELVIC DISPROPORTION : Sandostatin Side Effects Report #5399873-8
Consumer or non-health professional from JAPAN reported SANDOSTATIN LAR problem on July 20, 2007. Female patient, 37 years of age, weighting 183.0 lb, was diagnosed with acromegaly and was treated with SANDOSTATIN LAR. After drug was administered, patient experienced the following problems/side effects: caesarean section, cephalo-pelvic disproportion, foetal distress syndrome, induced labour, normal newborn, pregnancy induced hypertension, . SANDOSTATIN LAR dosage: 30 MG, ONCE/SINGLE. During the same period patient was treated with SANDOSTATIN LAR, SANDOSTATIN LAR, SANDOSTATIN LAR, SANDOSTATIN LAR, SANDOSTATIN LAR. Patient was hospitalized. Patient recovered.
CEPHALO-PELVIC DISPROPORTION : Sandostatin Side Effects Report #5399873-8
SANDOSTATIN LAR problem was reported by a Consumer or non-health professional from JAPAN on July 20, 2007. Female patient, 37 years of age, weighting 183.0 lb, was diagnosed with acromegaly and was treated with SANDOSTATIN LAR. After drug was administered, patient experienced the following problems/side effects: caesarean section, cephalo-pelvic disproportion, foetal distress syndrome, induced labour, normal newborn, pregnancy induced hypertension, . SANDOSTATIN LAR dosage: 30 MG, ONCE/SINGLE. During the same period patient was treated with SANDOSTATIN LAR, SANDOSTATIN LAR, SANDOSTATIN LAR, SANDOSTATIN LAR, SANDOSTATIN LAR. Patient was hospitalized. Patient recovered.